Analysed SCYNEXIS INC (SCYX:NASDAQ) News Sources
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
04-03-2026
yahoo.com
SCYNEXIS, Inc. (SCYX) Announces First Participants Dosed in Phase 1 Trial of SCY-247 Antifungal Therapy
12-03-2026
yahoo.com
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
31-03-2026
yahoo.com
SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease
31-03-2026
yahoo.com
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
11-05-2026
yahoo.com
What is the current price of SCYNEXIS INC (SCYX:NASDAQ)?
The current price of SCYNEXIS INC (SCYX:NASDAQ) is $4.23.
SCYNEXIS INC (SCYX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is $-0.015.
SCYNEXIS INC (SCYX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCYNEXIS INC (SCYX:NASDAQ) since the previous trading day is -0.3534%.
What is the most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent average sentiment score for SCYNEXIS INC (SCYX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for SCYNEXIS INC (SCYX:NASDAQ)?
The most recent sentiment for SCYNEXIS INC (SCYX:NASDAQ) is .
SEC-8K** Filing Available For SCYNEXIS INC (SCYX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.